Vycor Medical (VYCO) Cash from Operations (2010 - 2026)
Vycor Medical's (VYCO) quarterly Cash from Operations came in at -$4843.0 in Q2 2026, down 110.39% year-over-year from $46633.0 in Q2 2025, and down 104.87% quarter-over-quarter from $99422.0 in Q1 2026.
Powered by 
Analysis
Vycor Medical (VYCO) Cash from Operations (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Cash from Operations for 17 consecutive years, with -$4843.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Operations fell 110.39% year-over-year to -$4843.0 in Q2 2026; TTM through Jun 2026 was $61384.0, a 859.05% increase from a year earlier, with the FY2025 full-year figure at -$13471.0, down 122.41% from the prior year.
- Cash from Operations was -$4843.0 for Q2 2026 at Vycor Medical, down from $99422.0 in the prior quarter.
- Over five years, Cash from Operations peaked at $99422.0 in Q1 2026 and troughed at -$78780.0 in Q1 2022.
- A 5-year average of -$2576.0 and a median of -$1478.0 in 2024 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations jumped 507.41% in 2024 and tumbled 1526.02% in 2025, its largest moves.
- Over 5 years, Cash from Operations stood at -$33354.0 in 2022, then soared by 116.51% to $5508.0 in 2023, then sank by 795.01% to -$38281.0 in 2024, then surged by 202.48% to $39232.0 in 2025, then plunged by 112.34% to -$4843.0 in 2026.
- The last three Cash from Operations figures came in at -$4843.0 (Q2 2026), $99422.0 (Q1 2026), and $39232.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.41 Bn | 175.81 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 127.42 Bn | 122.20 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 117.31 Bn | 108.49 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 105.19 Bn | 101.72 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 64.84 Bn | 64.30 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.86 Bn | 45.61 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 33.12 Bn | 31.66 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 32.09 Bn | 30.15 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -4,843.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,843.00 |
| Mar 31, 2026 | 99,422.00 |
| Dec 31, 2025 | 39,232.00 |
| Sep 30, 2025 | -72,427.00 |
| Jun 30, 2025 | 46,633.00 |
| Mar 31, 2025 | -26,909.00 |
| Dec 31, 2024 | -38,281.00 |
| Sep 30, 2024 | 10,470.00 |
| Jun 30, 2024 | 86,034.00 |
| Mar 31, 2024 | 1,887.00 |
| Dec 31, 2023 | 5,508.00 |
| Sep 30, 2023 | -14,863.00 |
| Jun 30, 2023 | 14,164.00 |
| Mar 31, 2023 | 24,621.00 |
| Dec 31, 2022 | -33,354.00 |
| Sep 30, 2022 | -76,746.00 |
| Jun 30, 2022 | -28,136.00 |
| Mar 31, 2022 | -78,780.00 |
| Dec 31, 2021 | 31,453.00 |
| Sep 30, 2021 | -62,395.00 |